← Back to Search

Low-level Laser Therapy

Low-level Laser Therapy for Neck Pain

N/A
Recruiting
Led By Paul F Crawford, MD
Research Sponsored by Paul Crawford
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Active Duty US Air Force pilots or onboard navigators, aged 18- 62 years of age
History of neck pain for a period of more than two months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up record during screening visit
Awards & highlights

Study Summary

This trial will find the best way to treat neck pain using low-level laser therapy.

Who is the study for?
This trial is for active US Air Force pilots or navigators, aged 18-62, who can get care at Nellis Air Force Base. They should have had neck pain for over two months and a moderate disability score on the Neck Disability Index. Exclusions include those with open neck wounds, pacemakers, certain chronic diseases like fibromyalgia or rheumatoid arthritis, recent major surgery or trauma, pregnancy, and unstable cervical conditions.Check my eligibility
What is being tested?
The study aims to find out which low-level laser therapy (LLLT) device is best for treating neck pain in air force personnel. Participants will be divided into three groups; each group will receive treatment using different LLLT devices: Phoenix Thera-Lase Device or Pinnacle Series Laser Device.See study design
What are the potential side effects?
Low-level laser therapies are generally considered safe but may cause minor side effects such as slight discomfort at the site of application, mild redness or swelling. Serious side effects are rare.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am an active US Air Force pilot or navigator, aged 18-62.
Select...
I have had neck pain for over two months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 0 (screening visit), visit 1 (day 1), visit 10 (day 10)
This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 0 (screening visit), visit 1 (day 1), visit 10 (day 10) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Defense and Veterans Pain Rating Scale (DVPRS)
Change in Neck Disability Index (NDI)
Number of grounding days from flying due to neck pain -- Interval Variable
Secondary outcome measures
Change in C-reactive protein Biomarker Levels
Change in Interleukin 1 beta Biomarker Levels
Change in Interleukin 10 Biomarker Levels
+14 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Group 3 (Phoenix)Experimental Treatment1 Intervention
Utilizing the Phoenix Thera-Lase by Phoenix Thera-Lase Systems, we will apply LLT.
Group II: Group 2 (Pinnacle, higher dosimetry parameters)Experimental Treatment1 Intervention
Utilize the Pinnacle Series Laser by Aspen Laser Systems to apply LLLT
Group III: Group 1 (Pinnacle, lower dosimetry parameters)Experimental Treatment1 Intervention
Utilize the Pinnacle Series Laser by Aspen Laser Systems to apply LLLT

Find a Location

Who is running the clinical trial?

Paul CrawfordLead Sponsor
5 Previous Clinical Trials
671 Total Patients Enrolled
Paul F Crawford, MDPrincipal InvestigatorUS Air Force
7 Previous Clinical Trials
361 Total Patients Enrolled

Media Library

Phoenix Thera-Lase Device (Low-level Laser Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT03945240 — N/A
Neck Pain Research Study Groups: Group 1 (Pinnacle, lower dosimetry parameters), Group 2 (Pinnacle, higher dosimetry parameters), Group 3 (Phoenix)
Neck Pain Clinical Trial 2023: Phoenix Thera-Lase Device Highlights & Side Effects. Trial Name: NCT03945240 — N/A
Phoenix Thera-Lase Device (Low-level Laser Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03945240 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What objectives is this experiment aiming to fulfill?

"The primary objective of this medical trial, which will be evaluated at visits 0 (screening visit), 1 (day 1) and 10 (day 10) is to measure the alteration in Defense and Veterans Pain Rating Scale (DVPRS). Secondary goals include observing changes in Interleukin 4 biomarker levels with a standard curve range of 9.35-38300 pg/mL, fluctuations in Tumor Necrosis Factor - alpha levels between 6.42-26300 pg/mL, as well as alterations in Interleukin 12 values within a range of 1.56-6400 pg/mL; these measurements"

Answered by AI

Is it possible for me to join in this research endeavor?

"This medical trial requires 296 volunteers with neck pain and an age between 18 to 62 years old."

Answered by AI

Does this research endeavor accept volunteers who are 40 years old and older?

"This clinical trial adheres to the eligibility qualifications of 18 and 62 as the lower/upper bound for patient enrolment, respectively."

Answered by AI

To what extent is this clinical trial encompassing human participants?

"Affirmative. Evidence hosted on clinicaltrials.gov substantiates that the trial, which was initially published on October 1st 2020, is currently recruiting participants. In total, 296 patients need to be recruited from a single site."

Answered by AI

Are new participants still eligible to take part in this clinical experiment?

"Affirmative. The records on clinicaltrials.gov verify that this research is actively recruiting subjects; it was first submitted to the database in October 2020 and recently updated on January 13th 2022. A total of 296 individuals are intended to be enrolled across a single site."

Answered by AI
Recent research and studies
~80 spots leftby Sep 2025